Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors

J Infect. 2011 Mar;62(3):204-11. doi: 10.1016/j.jinf.2010.12.006. Epub 2010 Dec 24.

Abstract

Objectives: To report clinical characteristics and prognosis of vascular graft infections in Intensive Care Unit (ICU).

Methods: Thirty seven patients consecutively admitted in ICU for suspected or definite vascular graft infection between January 2006 and June 2009 were included.

Results: Staphylococcus species (n = 18) and enterobacteriae (n = 16) were the most frequent causative organisms. Twenty six patients (70%) needed mechanical ventilation. Further surgical procedures were performed in 7 patients (19%). In case of definite infection, mortality in ICU was 33%. In non survivors, shock (92% vs 42%, p = 0.01), age > 70 years (73% vs 27%, p = 0.04), POSSUM score > 45 (73% vs 27%, p = 0.04) and extra-anatomic bypass (45% vs 14%, p = 0.05) were more frequent, intra-operative volume of red cells transfusion (6 ± 3 vs 3 ± 2 units, p = 0.006) and of fresh frozen plasma (2.8 ± 2.8 vs 0.7 ± 1.2 units, p = 0.02), and SAPS II score (58 ± 26 vs 38 ± 17, p = 0.03) were higher. Proportion of adequate initial antibiotic therapy was similar in survivors and non survivors (91% vs 100%, p = 0.4). Proportion of patients treated with an aminoglycoside tended to be higher in survivors (59% vs 27%, p = 0.07). By multivariate analysis, only shock was associated with death in ICU (AOR: 16.3; 95% CI: 1.7-152.1; p = 0.01).

Conclusions: Vascular graft infection carries high morbidity and mortality rates in ICU. Extra-anatomic bypass might be associated with higher mortality. Early aminoglycoside prescription might be protective.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis / methods
  • Bacterial Infections / drug therapy
  • Bacterial Infections / epidemiology*
  • Bacterial Infections / mortality*
  • Female
  • Humans
  • Intensive Care Units
  • Male
  • Mycoses / drug therapy
  • Mycoses / epidemiology*
  • Mycoses / mortality*
  • Surgical Wound Infection / drug therapy
  • Surgical Wound Infection / epidemiology*
  • Surgical Wound Infection / mortality*
  • Survival Analysis
  • Vascular Grafting / adverse effects*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents